Stay updated on AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.

Latest updates to the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page
- ChecktodayChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1 while the study page remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe detailed study record content was deleted and replaced with a 403 Forbidden page, leaving only a basic header and navigation; the page now shows a restricted access state.SummaryDifference17%

- Check42 days agoChange DetectedThe page footer revision was updated from v3.6.5 to v3.6.6, signaling a new release of the page template. This update does not change study information or user-facing functionality.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now displays Revision: v3.6.5, indicating a backend/template update to the study record; no study content appears to be altered.SummaryDifference16%

- Check78 days agoChange DetectedThe page shows an updated revision tag from v3.6.3 to v3.6.4, signaling a release update to the page or site software. This change does not alter study content or user-facing information.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3, indicating a software revision was applied.SummaryDifference0.1%

Stay in the know with updates to AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.